Skip to main content
Log in

Increased clinical symptoms of acromegalic arthropathy in patients with long-term disease control: a prospective follow-up study

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Arthropathy is an invalidating complication of acromegaly. This arthropathy deteriorates radiographically despite long-term disease control. However, the clinical course and its relationship to the radiographic course are currently unknown. We aimed to investigate the clinical course of arthropathy during follow-up and its relationship to radiographic progression in long-term controlled acromegaly patients. Prospective follow-up study. We studied 58 patients (mean age 62 years, women 41 %) with controlled acromegaly for a mean of 17.6 years. Clinical progression of joint disease was defined at baseline and after 2.6 years, by the Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) and Australian/Canadian Osteoarthritis Index (AUSCAN) questionnaires for lower limb and hand OA, respectively, and performance tests. Potential risk factors for progression were assessed. The clinical course of arthropathy was related to the radiographic course. On average, hand and lower limb function deteriorated during follow-up, despite large interindividual variations. Joint pain was stable over time. High levels of pain and functional impairment at baseline were related to clinical progression of hand pain and functional limitations. High baseline BMI was a risk factor for functional deterioration in the lower limb. The changes in symptoms and radiographic progression during follow-up were not related. In treated acromegaly patients, joint function deteriorates during prolonged follow-up, despite biochemical disease control, although there was interindividual variation. Clinical and radiographic course of arthropathy were not related. Therefore, in clinical practice, a combination of clinical and radiographic assessment is necessary to evaluate the course of acromegalic arthropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F (2005) Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 90(5):2731–2739

    Article  CAS  PubMed  Google Scholar 

  2. Barkan A (1997) Acromegalic arthropathy and sleep apnea. J Endocrinol 155(Suppl 1):S41–S44

    PubMed  Google Scholar 

  3. Wassenaar MJ, Biermasz NR, Bijsterbosch J et al (2011) Arthropathy in long-term cured acromegaly is characterised by osteophytes without joint space narrowing: a comparison with generalised osteoarthritis. Ann Rheum Dis 70(2):320–325

    Article  CAS  PubMed  Google Scholar 

  4. Wassenaar MJ, Biermasz NR, Biermasz NR, Van DN et al (2009) High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study. Eur J Endocrinol 160(3):357–365

    Article  CAS  PubMed  Google Scholar 

  5. Wassenaar MJ, Biermasz NR, Kloppenburg M et al (2010) Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients. Growth Horm IGF Res 20(3):226–233

    Article  CAS  PubMed  Google Scholar 

  6. Claessen KM, Ramautar SR, Pereira AM et al (2012) Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study. Eur J Endocrinol 167(2):235–244

    CAS  PubMed  Google Scholar 

  7. Biermasz NR, Dekker FW, Pereira AM et al (2004) Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. J Clin Endocrinol Metab 89(6):2789–2796

    Article  CAS  PubMed  Google Scholar 

  8. Biermasz NR, van DH, Roelfsema F (2000) Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab 85(12):4596–4602

    CAS  PubMed  Google Scholar 

  9. Roelfsema F, van DH, Frolich M (1985) Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clin Endocrinol (Oxf) 23(5):555–565

    Article  CAS  Google Scholar 

  10. van der Klaauw AA, Kars M, Biermasz NR et al (2008) Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf) 69(5):775–784

    Article  Google Scholar 

  11. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15(12):1833–1840

    CAS  PubMed  Google Scholar 

  12. Bellamy N, Campbell J, Haraoui B et al (2002) Clinimetric properties of the AUSCAN Osteoarthritis Hand Index: an evaluation of reliability, validity and responsiveness. Osteoarthr Cartil 10(11):863–869

    Article  CAS  PubMed  Google Scholar 

  13. Bourbonnais D, Frak V, Pilon JF, Goyette M (2008) An instrumented cylinder measuring pinch force and orientation. J Neuroeng Rehabil 5:2

    Article  PubMed Central  PubMed  Google Scholar 

  14. Sancho-Bru JL, Giurintano DJ, Perez-Gonzalez A, Vergara M (2003) Optimum tool handle diameter for a cylinder grip. J Hand Ther 16(4):337–342

    Article  PubMed  Google Scholar 

  15. Peterfy C, Li J, Zaim S et al (2003) Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility. Skeletal Radiol 32(3):128–132

    Article  CAS  PubMed  Google Scholar 

  16. Altman RD, Hochberg M, Murphy WA Jr, Wolfe F, Lequesne M (1995) Atlas of individual radiographic features in osteoarthritis. Osteoarthr Cartil 3 Suppl A:3–70

    CAS  PubMed  Google Scholar 

  17. Bellamy N, Wilson C (2007) International estimation of minimally clinically important improvement (MCII75): the Reflect Study. Intern Med J 37:A36

    Google Scholar 

  18. Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N (2000) Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol 27(11):2635–2641

    CAS  PubMed  Google Scholar 

  19. Bruynesteyn K, Boers M, Kostense P, der Van LS, der Van HD (2005) Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Ann Rheum Dis 64(2):179–182

    Article  CAS  PubMed  Google Scholar 

  20. Cole TJ, The LMS (1990) Method for constructing normalized growth standards. Eur J Clin Nutr 44(1):45–60

    CAS  PubMed  Google Scholar 

  21. Rikken B, van DJ, Rikken B, Ringeling A, Massa G, Wit JM, Van den Brande JL (1998) Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res 50(3):166–176

    Article  CAS  PubMed  Google Scholar 

  22. Biermasz NR, van Thiel SW, Pereira AM et al (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89(11):5369–5376

    Article  CAS  PubMed  Google Scholar 

  23. Okazaki K, Jingushi S, Ikenoue T et al (1999) Expression of insulin-like growth factor I messenger ribonucleic acid in developing osteophytes in murine experimental osteoarthritis and in rats inoculated with growth hormone-secreting tumor. Endocrinology 140(10):4821–4830

    CAS  PubMed  Google Scholar 

  24. Barkan AL (2001) Acromegalic arthropathy. Pituitary 4(4):263–264

    Article  CAS  PubMed  Google Scholar 

  25. Bijsterbosch J, Watt I, Meulenbelt I, Rosendaal FR, Huizinga TW, Kloppenburg M (2011) Clinical and radiographic disease course of hand osteoarthritis and determinants of outcome after 6 years. Ann Rheum Dis 70(1):68–73

    Article  CAS  PubMed  Google Scholar 

  26. Riyazi N, Meulenbelt I, Kroon HM et al (2005) Evidence for familial aggregation of hand, hip, and spine but not knee osteoarthritis in siblings with multiple joint involvement: the GARP study. Ann Rheum Dis 64(3):438–443

    Article  CAS  PubMed  Google Scholar 

  27. Botha-Scheepers S, Watt I, Rosendaal FR, Breedveld FC (2008) Hellio le Graverand MP, Kloppenburg M. Changes in outcome measures for impairment, activity limitation, and participation restriction over 2 years in osteoarthritis of the lower extremities. Arthritis Rheum 59(12):1750–1755

    Article  PubMed  Google Scholar 

  28. Botha-Scheepers S, Riyazi N, Watt I et al (2009) Progression of hand osteoarthritis over 2 years: a clinical and radiological follow-up study. Ann Rheum Dis 68(8):1260–1264

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research did not receive any specific Grant from any funding agency in the public, commercial or not-for-profit sector.

Conflict of interest

There is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. M. J. A. Claessen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Claessen, K.M.J.A., Ramautar, S.R., Pereira, A.M. et al. Increased clinical symptoms of acromegalic arthropathy in patients with long-term disease control: a prospective follow-up study. Pituitary 17, 44–52 (2014). https://doi.org/10.1007/s11102-013-0464-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-013-0464-6

Keywords

Navigation